300016.SZ
Beijing Beilu Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.74
−6.70%Year over year
Reported trailing growth
- Revenue
- +17.4%
- EBITDA
- —
- EBIT
- —
- EPS
- +613.2%
- Free cash flow
- -93.3%
- Operating cash flow
- +35.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +16.3%
- EBITDA
- +48.6%
- EBIT
- —
- Net income
- +101.8%
- EPS
- +108.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026